Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jonathan C Lansing"'
Autor:
Nathaniel Washburn, Robin Meccariello, Shaohui Hu, Maurice Hains, Naveen Bhatnagar, Hetal Sarvaiya, Bulbul Kapoor, John Schaeck, Ignacio Pino, Anthony Manning, Jonathan C Lansing, Carlos J Bosques
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181251 (2017)
Intravenous immunoglobulin (IVIg) is a complex mixture drug comprising diverse immunoglobulins and non-IgG proteins purified from the plasma of thousands of healthy donors. Approved IVIg products on the market differ regarding source of plasma, isola
Externí odkaz:
https://doaj.org/article/810e740f2ece44d3987135491a036d73
Autor:
Robert Prenovitz, Nathaniel Washburn, Jay Duffner, Carlos J. Bosques, Anthony M. Manning, Ganesh Kaundinya, Robin Meccariello, Jonathan C. Lansing, Thomas Prod’homme, Ishan Capila, Karunya Srinivasan, Kristen Getchell, Kimberly Holte
Publikováno v:
Molecular & Cellular Proteomics : MCP
Characterization of endogenous FcγRIII glycosylation from healthy donors with different FcγRIIIb genotypes reveals site specific, and allele specific differences in glycosylation as well as noncananonical sequence specific differences in glycosylat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aefb5da0df94b01a05bcaf91520eaf3c
https://doi.org/10.1074/mcp.ra118.001142
https://doi.org/10.1074/mcp.ra118.001142
Autor:
Jonathan C. Lansing, James Anderson, Christine Bell, James H. Prescott, John Bishop, Joseph Glajch, Ishan Capila, Richard Sachleben, Bruce A. Cohen, Mani Iyer, Daniel Kantor, Ganesh Kaundinya, Joel Pradines, Tanmoy Ganguly
Publikováno v:
Journal of the Neurological Sciences. 359:24-34
Glatiramer acetate (GA) has been available under the brand name Copaxone® for nearly two decades. Recently, the US Food and Drug Administration (FDA) approved the first generic GA, Glatopa™, as fully substitutable for all indications for which Cop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9685fe7cfcc8113789c68001c56f186
https://doi.org/10.1016/j.jns.2015.10.007
https://doi.org/10.1016/j.jns.2015.10.007
Autor:
Richard Sachleben, James Roach, Tanmoy Ganguly, Benjamin Greenberg, Jonathan C. Lansing, Daniel Kantor, Ian Fier, James H. Prescott, Hall Steven E, Christine Bell, Paul J. Miller, Kavita V. Nair, Kristina Storey, Ishan Capila, Joseph Glajch, James M. Anderson, Mani Iyer
Publikováno v:
Journal of pharmacy practice, vol 31, iss 5
The multiple sclerosis (MS) treatment landscape in the United States has changed dramatically over the past decade. While many disease-modifying therapies (DMTs) have been approved by the US Food and Drug Administration (FDA) for the treatment of rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca70b152ba0ebfb57b69915a776b609b
https://escholarship.org/uc/item/8k30d36z
https://escholarship.org/uc/item/8k30d36z
Autor:
Laura Rutitzky, Daniel F. Ortiz, Jonathan C. Lansing, Julia Brown, Joseph Paquette, Kevin Garofalo, Josephine D'Alessandro, Naveen Bhatnagar, Maurice Hains, Abhinav Gupta, Stan Lee, Radouane Zouaoui, Jason Wang, John Schaeck, Salvatore Marchese, Robin Meccariello, Nathaniel Washburn, Kimberly Holte, Carlos J. Bosques, Anthony M. Manning
Publikováno v:
Cancer Research. 79:3244-3244
Numerous therapeutic monoclonal antibodies (mAbs) rely on antibody-dependent cell cytotoxicity (ADCC), antibody-dependent cell phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC) Fc effector functions to deplete target cells and achieve c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf0c014a499f281c36f74e93ab3210ff
https://doi.org/10.1158/1538-7445.am2019-3244
https://doi.org/10.1158/1538-7445.am2019-3244
Autor:
Jonathan C. Lansing, Anthony M. Manning, Amit Choudhury, Edward Cochran, Jason K. Wang, Shannon Argueta, Kevin Garofalo, Abhinav Gupta, Naveen Bhatnagar, Carlos J. Bosques, Daniel Ortiz, Stan Lee, Viraj Parge, Karunya Srinivasan, Utsav Jetley, Jay Duffner, Danice Wilkins, Radouane Zouaoui
Publikováno v:
Cancer Research. 79:561-561
CD38 targeting antibodies are at different phases of clinical development, with daratumumab already approved as monotherapy and in combination with standards of care in multiple myeloma (MM). Anti-CD38 monoclonal antibodies (mAbs) induce tumor cell d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f7c53612798a558fb19d4896b6641d
https://doi.org/10.1158/1538-7445.am2019-561
https://doi.org/10.1158/1538-7445.am2019-561
Autor:
Maurice Hains, Kimberly Holte, Amit Choudhury, Daniel Ortiz, Christopher Beneduce, Jonathan C. Lansing, Thomas Prod’homme, Steven Tyler, Robert Prenovitz, Lynn Markowitz, Elma Kurtagic, Allison Simpson, Laura I. Rutitzky, Julia Brown, Leona E. Ling, Stephanie Nguyen, Birgit Schultes, Ishan Capila, Anthony M. Manning, Robin Meccariello, Inessa Schwab, Nathaniel Washburn, Carlos J. Bosques, Matthew A. Child, Radouane Zouaoui, Jason Killough, Falk Nimmerjahn, Jing Wang, Naveen Bhatnagar
Publikováno v:
Science Translational Medicine. 8
Autoantibody immune complex (IC) activation of Fcγ receptors (FcγRs) is a common pathogenic hallmark of multiple autoimmune diseases. Given that the IC structural features that elicit FcγR activation are poorly understood and the FcγR system is h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dccfaa1f5bb42ddec8bfc28ba84dedf7
https://doi.org/10.1126/scitranslmed.aaf9418
https://doi.org/10.1126/scitranslmed.aaf9418
Autor:
Zachary Shriver, Lucinda F. Buhse, Robert Langer, Gregory Scott Bailey, Sean W. Smith, Mark T. Whary, Ram Sasisekharan, Blair A. Fraser, James G. Fox, Karthik Viswanathan, K. Frank Austen, Thomas Rogers-Cotrone, Kevin D. Pelzer, Sucharita Roy, Moheb Nasr, Zoya Galcheva-Gargova, Subbiah Elankumaran, Ganlin Zhao, Tanmoy Ganguly, Takashi Kei Kishimoto, Gerald J. Dal Pan, Nammalwar Sriranganathan, Jonathan C. Lansing, Janet Woodcock, Ganesh Venkataraman, Ali Al-Hakim
Publikováno v:
New England Journal of Medicine. 358:2457-2467
BACKGROUND There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ff1d39ea9993869e9169cfe0efae23
https://doi.org/10.1056/nejmoa0803200
https://doi.org/10.1056/nejmoa0803200
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Autor:
Janet Woodcock, Zhenqing Zhang, Daniela Beccati, Blair A. Fraser, Giangiacomo Torri, Jonathan C. Lansing, Antonella Bisio, Luke Robinson, Robert J. Linhardt, Sara Guglieri, Moheb Nasr, Benito Casu, Annamaria Naggi, Nur Sibel Gunay, Ram Sasisekharan, Ali Al-Hakim, Ganesh Venkataraman, Ishan Capila, Marco Guerrini, Karthik Viswanathan, Robert Langer, Zachary Shriver, Lucinda F. Buhse
Publikováno v:
Nature Biotechnology. 26:669-675
Heparin has been used clinically as an anticoagulant for over 60 years. Typically isolated from porcine intestine, heparin is a mixture of dimeric glycosidic sequences generating complex polysaccharide glycosaminoglycan chains. Recently, certain lots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7480c5f1b3f52c148c75c2c11534ed4
https://doi.org/10.1038/nbt1407
https://doi.org/10.1038/nbt1407
Publikováno v:
International Journal of Mass Spectrometry
International Journal of Mass Spectrometry, Elsevier, 2015, 391, pp.115--122. ⟨10.1016/j.ijms.2015.09.002⟩
International Journal of Mass Spectrometry, 2015, 391, pp.115--122. ⟨10.1016/j.ijms.2015.09.002⟩
International Journal of Mass Spectrometry, Elsevier, 2015, 391, pp.115--122. ⟨10.1016/j.ijms.2015.09.002⟩
International Journal of Mass Spectrometry, 2015, 391, pp.115--122. ⟨10.1016/j.ijms.2015.09.002⟩
A novel workflow was designed for the large-scale identification of protein N-terminal sequences. The workflow started with converting lysine to homoarginine, followed by reaction with sulfonation of N-termini by 4-sulfophenyl isothiocyanate (SPITC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a39fe9869be0ed18bb2d3ce20b1d9a8
https://hal.archives-ouvertes.fr/hal-01665233
https://hal.archives-ouvertes.fr/hal-01665233